Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
| Actual shortage: | 12 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 3 (75%) | |
| Discontinued: | 1 (25%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
9 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| STERILE WATER FOR INJECTION USP | 100% | SOLUTION | Resolved | 2018-04-04 | 2018-04-26 | 44911 |
| STERILE WATER FOR INJECTION USP | 100% | SOLUTION | Resolved | 2021-07-20 | 2022-01-25 | 142812 |
| STERILE WATER FOR INJECTION USP | 100% | SOLUTION | Resolved | 2022-02-04 | 2022-08-16 | 154254 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2018-02-15 | 2018-03-08 | 39965 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2018-04-04 | 2018-04-27 | 44923 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2021-01-29 | 2021-04-15 | 132779 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2021-07-20 | 2023-01-20 | 142809 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4MG | SOLUTION | Resolved | 2018-10-30 | 2019-06-20 | 65888 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4MG | SOLUTION | Actual shortage | 2023-11-17 | 2024-04-09 | 210664 |
| FUROSEMIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2017-12-22 | 2018-04-27 | 34270 |
| FUROSEMIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-11-17 | 2024-02-14 | 210680 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2018-08-22 | 2018-10-11 | 58777 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2019-02-05 | 2019-02-28 | 74781 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Actual shortage | 2023-10-02 | 2023-11-02 | 205826 |
| ENALAPRILAT INJECTION USP | 1.25MG | SOLUTION | Resolved | 2017-07-31 | 2017-09-13 | 17559 |
| ENALAPRILAT INJECTION USP | 1.25MG | SOLUTION | Actual shortage | 2023-12-19 | 2024-03-01 | 213843 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2018-02-15 | 2018-03-10 | 39953 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2022-04-14 | 2022-09-08 | 158884 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-10-20 | 2024-03-06 | 207616 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-10-20 | 2024-04-09 | 207619 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 4 of 4